Visit our website
Recognition from the world Health Organization (wHO) for polio vaccines (9 April 1997), measles 10 doses & 20 doses (9 April 1997 & 4 September 2006), Hepatitis B Uniject (13 May 2004), Oral Polio Vaccine Tipe 1/mOPV-1 monovalent (3 November 2009), Oral Polio Vaccine/bOPV bivalent (26 May 2010), bacterial vaccines (Diphtheria, Pertussis, Tetanus) (6 April 2011), Tetanus in vial form (11 March 1999) & Uniject (29 October 2003), Td (6 July 2011), DT (11 March 1999) and DTP-HB combination vaccine, have all passed the wHO prequalified test (7 October 2004), Pentabio (16 December 2014).
Bio Farma mendapatkan sertifikat ISO 9001 : 2015 mengenai Standar Manajemen Mutu yang diberikan oleh L'loyds Register Quality Assurance tanggal 27 Juni 2016 - 26 Juni 2019
Laboratorium Mikrobiologi Bio Farma mendapatkan Akreditasi ISO 17025 untuk pengujian produk makanan, minuman dan kosmetik
CPOB (Good Manufacturing Practice) from National Agency of Drugs and Food Control of the Republic of Indonesia :
ISO 14001:2004 certification for Environmental Management System wasgiven by Lloyd’s Register Quality Assurance Ltd., Singapore, valid until 30 juni 2016
Occupational, Health and Safety Management System–OHSAS 18001:2007 for the management of occupational security, safety and health was given by Lloyd’s Register Quality Assurance Ltd., Singapore. Valid until 16 September 2015.
Laboratory Accreditation Certificate was given by the world Health Organization (wHO) Regional South East Asia and Immunization and Vaccine Development (IVD) to Bio Farma for passing the accreditation for the laboratorium facility as a reference for polio laboratory test. Valid until December 2013.
Certificate of Honor from the world Health Organization (WHO) in implementing the use of Vaccine Vial Monitor (VVM) for Indonesia through Bio Farma.
Bio Farma received an appreciation from the Bill & Melinda Gates Foundation. This Certificate of Appreciation was given for Bio Farma’s commitment and dedication in improving global health, among others in eradicating polio disease by producing twothird of the world’s global demand for Oral Polio Vaccine (OPV).